Nuzenio

For Apogee Therapeutics

For Apogee Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Tue, 11 Aug 2026 06:04:47 GMTApogee Therapeutics Positive Interim Results From Phase 1b Trial Of Zumilokibart (APG777) | Jan 06 Gorton School Lockdown (mvSdngPTwI) - Mshale
Tue, 11 Aug 2026 04:52:58 GMTAPGE SWOT Analysis: Financial Resilience Amidst Clinical Challenges Revealed in 10-Q Filing - GuruFocus
Mon, 10 Aug 2026 13:59:48 GMTApogee Therapeutics Reports Q2 2026 Results and Announces Merger Agreement with AbbVie Subsidiary - Kalkine Media
Mon, 10 Aug 2026 12:01:01 GMTApogee Therapeutics 2Q 2026: Net loss $85.9M, First half loss $160M — 10-Q Summary - TradingView
Mon, 10 Aug 2026 11:53:11 GMTApogee Therapeutics (APGE) details Q2 2026 losses, AbbVie merger plan and $100M BXLS deal - Stock Titan
Mon, 10 Aug 2026 11:41:44 GMTApogee Therapeutics (NASDAQ:APGE) Issues Earnings Results, Misses Expectations By $1.00 EPS - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for For Apogee Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.